Literature DB >> 22360297

Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.

Deborah M Stein1, Allison L Lindell, Karen R Murdock, Joseph A Kufera, Jay Menaker, Grant V Bochicchio, Bizhan Aarabi, Thomas M Scalea.   

Abstract

The management of severe traumatic brain injury (TBI) focuses on prevention and treatment of secondary insults such as cerebral hypoxia (CH). There are a number of biomarkers that are thought to play a part in secondary injury following severe TBI. This study evaluates the association between S100β, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), detected in the serum of severe TBI patients and CH as measured by brain tissue oxygen partial pressure (Pbo(2)). Patients with severe TBI were prospectively enrolled. Pressure times time (PTD; mm Hg*h), measuring the depth and duration of CH, was calculated for 12-h periods for episodes of moderate (Pbo(2) < 20 mm Hg) and severe (Pbo(2) < 15 mm Hg) CH, and compared to serum levels of S100β, NSE, and GFAP drawn prior to periods of monitoring. An adjusted mixed model analysis was applied as was receiver operating characteristic (ROC) curve analysis. Of 76 patients enrolled, 24 had Pbo(2) monitoring. One hundred and thirty serum samples were matched with 12-h periods of monitoring. Significant associations were found in adjusted analyses between increasing serum levels of S100β (coefficient=0.57, 0.56; p<0.001), NSE (coefficient=0.48, 0.52; p<0.001), and GFAP (coefficient=0.29, 0.30; p=0.003 and 0.002), and increasing PTD of moderate (Pbo(2)<20 mm Hg) and severe (Pbo(2)<15 mm Hg) CH. AUCs for the prediction of moderate and severe CH were 0.62 and 0.66 for S100β, 0.55 and 0.71 for NSE, and 0.50 and 0.62 for GFAP, respectively. Specificities were between 76% and 90% for S100β and NSE. S100β, NSE, and GFAP demonstrate promise as candidate serum markers of impending CH. The fact that these biomarker elevations occur prior to the onset of clinical manifestations suggests that we may be able to predict imminent events following TBI. Given the morbidity of CH, early intervention and prevention may have a significant impact on outcomes and help guide decisions about the timing of interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22360297     DOI: 10.1089/neu.2011.2149

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  17 in total

1.  The role of cardiac troponin I in prognostication of patients with isolated severe traumatic brain injury.

Authors:  Stephen S Cai; Brandon W Bonds; Peter F Hu; Deborah M Stein
Journal:  J Trauma Acute Care Surg       Date:  2016-03       Impact factor: 3.313

Review 2.  Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.

Authors:  Zhihui Yang; Kevin K W Wang
Journal:  Trends Neurosci       Date:  2015-05-11       Impact factor: 13.837

3.  Predictive value of neuron-specific enolase for prognosis in patients with moderate or severe traumatic brain injury: a systematic review and meta-analysis.

Authors:  Eric Mercier; Amélie Boutin; Michèle Shemilt; François Lauzier; Ryan Zarychanski; Dean A Fergusson; Lynne Moore; Lauralyn A McIntyre; Patrick Archambault; France Légaré; François Rousseau; François Lamontagne; Linda Nadeau; Alexis F Turgeon
Journal:  CMAJ Open       Date:  2016-07-22

4.  Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.

Authors:  Ryan P Lange; Allen Everett; Pratima Dulloor; Frederick K Korley; Chetan Bettegowda; Cherie Blair; Stuart A Grossman; Matthias Holdhoff
Journal:  Cancer Invest       Date:  2014-07-14       Impact factor: 2.176

5.  Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury.

Authors:  Eric P Thelin; David W Nelson; Bo-Michael Bellander
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

6.  Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.

Authors:  Edwin B Yan; Laveniya Satgunaseelan; Eldho Paul; Nicole Bye; Phuong Nguyen; Doreen Agyapomaa; Thomas Kossmann; Jeffrey V Rosenfeld; Maria Cristina Morganti-Kossmann
Journal:  J Neurotrauma       Date:  2014-01-09       Impact factor: 5.269

7.  The diagnosis of traumatic brain injury on the battlefield.

Authors:  Kara E Schmid; Frank C Tortella
Journal:  Front Neurol       Date:  2012-06-12       Impact factor: 4.003

Review 8.  Biomarkers in septic encephalopathy: a systematic review of clinical studies.

Authors:  Paula Veriato Zenaide; Dimitri Gusmao-Flores
Journal:  Rev Bras Ter Intensiva       Date:  2013-03

Review 9.  The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis.

Authors:  Feng Cheng; Qiang Yuan; Jian Yang; Wenming Wang; Hua Liu
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

Review 10.  Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis.

Authors:  Donna M Wilcock; W Sue T Griffin
Journal:  J Neuroinflammation       Date:  2013-07-16       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.